miltefosine has been researched along with Granulomas in 4 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Excerpt | Relevance | Reference |
---|---|---|
"A dual drug repurposing/nanotechnological approach was used to develop an alternative oral treatment for schistosomiasis mansoni using miltefosine (MFS), an anticancer alkylphosphocholine, and lipid nanocapsules (LNCs) as oral nanovectors." | 7.83 | Miltefosine lipid nanocapsules: Intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoni. ( Eissa, MM; El-Azzouni, MZ; El-Khordagui, LK; El-Moslemany, RM; Ramadan, AA, 2016) |
"A dual drug repurposing/nanotechnological approach was used to develop an alternative oral treatment for schistosomiasis mansoni using miltefosine (MFS), an anticancer alkylphosphocholine, and lipid nanocapsules (LNCs) as oral nanovectors." | 3.83 | Miltefosine lipid nanocapsules: Intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoni. ( Eissa, MM; El-Azzouni, MZ; El-Khordagui, LK; El-Moslemany, RM; Ramadan, AA, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Eissa, MM | 2 |
El-Azzouni, MZ | 2 |
El-Khordagui, LK | 2 |
Abdel Bary, A | 1 |
El-Moslemany, RM | 2 |
Abdel Salam, SA | 1 |
Ramadan, AA | 1 |
Aichelburg, AC | 1 |
Walochnik, J | 1 |
Assadian, O | 1 |
Prosch, H | 1 |
Steuer, A | 1 |
Perneczky, G | 1 |
Visvesvara, GS | 2 |
Aspöck, H | 1 |
Vetter, N | 1 |
Webster, D | 1 |
Umar, I | 2 |
Kolyvas, G | 1 |
Bilbao, J | 1 |
Guiot, MC | 1 |
Duplisea, K | 1 |
Qvarnstrom, Y | 1 |
4 other studies available for miltefosine and Granulomas
Article | Year |
---|---|
Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni.
Topics: Animals; Anthelmintics; Disease Models, Animal; Drug Carriers; Drug Combinations; Granuloma; Lipids; | 2020 |
Miltefosine lipid nanocapsules: Intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoni.
Topics: Administration, Oral; Animals; Disease Models, Animal; Drug Repositioning; Granuloma; Liver; Mice; N | 2016 |
Successful treatment of disseminated Acanthamoeba sp. infection with miltefosine.
Topics: Acanthamoeba; Administration, Oral; Administration, Topical; Adult; Amebiasis; Animals; Antiprotozoa | 2008 |
Treatment of granulomatous amoebic encephalitis with voriconazole and miltefosine in an immunocompetent soldier.
Topics: Acanthamoeba; Adult; Amebiasis; Animals; Encephalitis; Granuloma; Humans; Immunocompetence; Male; Mi | 2012 |